This case underscores the importance of clinician awareness given its increasing, and often unregulated, use for weight loss
Maintaining a balanced diet may be tricky where side effects (such nausea) are persistent
The FDA recommends Wegovy for weight loss if you meet one of the following criteria: Have a body mass index (BMI) of 27kg/m2 or greater and at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol Have a BMI of 30kg/m2 or greater Avoid semaglutide if you have: History of medullary thyroid cancer History of gallbladder disease History of pancreatitis Multiple endocrine neoplasia syndrome type 2 (MEN2) If youre considering semaglutide for weight loss, your first step should be consulting your primary care physician (PCP)
Reach Your Goals We want to see you succeed and live a longer, happier, and healthier life
This makes it crucial for medical aestheticians and providers to incorporate psychological screenings, counseling, and ongoing support as part of comprehensive patient care
Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program